Cambridge Cognition Holdings Plc (AIM:COG)
26.00
-1.50 (-5.45%)
Nov 6, 2026, 1:23 PM GMT
AIM:COG Market Cap
AIM:COG has a market cap or net worth of 12.1 million as of November 6, 2026. It is the 38,158th most valuable company in the world and the 827th biggest in the United Kingdom. Its market cap has decreased by 12.39% in one year.
Market Cap
12.10M
Enterprise Value
11.76M
Revenue
10.13M
Global Rank
Country Rank
#827 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since April 18, 2013, AIM:COG's market cap has decreased from 13.12M to 12.10M, a decrease of -7.72%. That is a compound annual growth rate of -0.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 12.80M | 9.22% |
| Dec 31, 2025 | 11.72M | -24.92% |
| Dec 31, 2024 | 15.61M | -2.50% |
| Dec 29, 2023 | 16.01M | -54.81% |
| Dec 30, 2022 | 35.44M | -9.78% |
| Dec 31, 2021 | 39.28M | 88.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.52B |
| GSK plc | 75.77B |
| Haleon | 29.74B |
| Smith & Nephew | 9.96B |
| genedrive | 15.98M |
| Inspiration Healthcare Group | 15.30M |
| Oxford BioDynamics | 13.44M |
| SkinBioTherapeutics | 13.02M |